Currently Viewing:
Association of Community Cancer Centers Annual Meeting
The Price of Innovation When Improving Cancer Care Delivery
March 15, 2018
Currently Reading
Dr James Hamrick Outlines Challenges of Managing Clinical Trials and Benefits of Community Practices
March 15, 2018
Why Tom Gallo Wants to Address Burnout During His Year as ACCC President
March 15, 2018
Roger Holzberg Discusses Integrating Technology Into Healthcare
March 16, 2018
Investing in the Vital Role of a Cancer Care Coordinator
March 16, 2018
Barbara Tofani: The United States Underestimated the Need for Care Coordination
March 16, 2018
Technology Integration in Community Oncology Practice: Building the Future
March 16, 2018
Experts Emphasize the Value of Cancer Care Integration at ACCC Meeting
March 21, 2018
Tom Gallo: Burnout Needs to Be Addressed for All Members of the Care Team
April 03, 2018
Tom Gallo Discusses How Burnout Is Increasing and the Role of Technology
April 06, 2018
Dr Kathleen Blake Discusses the Impact Healthcare Industry Changes Have on Burnout
April 23, 2018
Dr Mark Soberman on the Next Generation Multidisciplinary Cancer Care Team
April 27, 2018
Dr Mark Soberman on the Importance of Communication Among Integrated Care Teams
May 01, 2018
Dr Charles Saunders Outlines the Increasing Importance of Technology in Practices
May 03, 2018
Barbara Tofani: The Old Ways of Coordinating Care Are Gone
May 07, 2018
Dr James Hamrick: Community Practices Help Increase Diversity in Clinical Trials
May 08, 2018
Dr Kathleen Blake Highlights Telltale Signs of Burnout
May 10, 2018
Dr Yousuf Zafar Discusses the Burden of Financial Toxicity and Trends Over Time
May 14, 2018
Thomas Asfeldt Highlights 3 Key Challenges to Creating Integrated Cancer Care Teams
May 15, 2018
Pamela Tobias Discusses Pulling Data from EHRs to Improve Processes
May 15, 2018
Dr Mark Soberman Discusses Integrated Care Teams in Oncology
May 16, 2018
Dr Charles Saunders Highlights Data Collection Challenges
May 18, 2018
Dr Kathleen Blake Outlines How Burnout Affects Specialties Differently
May 21, 2018
Barbara Tofani Outlines Best Practices and Mistakes of Care Coordination
May 22, 2018

Dr James Hamrick Outlines Challenges of Managing Clinical Trials and Benefits of Community Practices

The increasing complexity and personalization of clinical trials are major challenges for managing clinical trials, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.
 


The increasing complexity and personalization of clinical trials are major challenges for managing clinical trials, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.

Transcript

What is the biggest challenge you face in managing clinical trials?

First of all, to me, the practices in the community that invest in clinical trials really do understand that access to cutting-edge trials really is a hallmark of excellence in cancer care. And it really does take motivation from the practice because to run a clinical trial through your practice does require a significant deviation from your usual clinical workflow.

Some of the barriers that are increasingly happening in the community are the complexity of the trials—so it used to be that we had a straight-forward, traditional clinical trial on breast cancer patients, and now we’re dividing breasts cancer into further and further, more personalized cohorts. It may be an ER+ HER2- breast cancer in the metastatic setting. And that does a couple of things. One, it increases your complexity for your clinical staff; and 2, it makes the number of patients that are relevant to the trial smaller.

The increasing complexity of trials, the increasing personalization of trials, it’s a huge opportunity, and it introduces new efficiencies in terms of answering questions, but it’s also a challenge, especially in the community, for community practices, where they’re dealing with every different kind of cancer.

In addition, the same old challenge that we’ve had for years and years is that running a trial is simply a big disruption from your core workflow, which is the clinical care of patients. For a physician to transform what they’re doing for a specific patient from standard of care to a research protocol has been a very burdensome and time-consuming step, and that’s always going to be a headwind against which the practice is flying when they’re trying to participate in research.

I think there’s a huge opportunity for technology and smart smarter trial design to make the trials less disruptive to the clinical workflow. And with that I think we’ll see more accrual of patients.

What is the importance of utilizing community oncology practices when enrolling patients in clinical trials?

As we know, most of the oncology care in the United States happens out in the community, away from the large tertiary centers and you just have to have that population represented in your trials. We need trials that really represent the real world and that have more pragmatic designs. What I mean by that is they have somewhat looser inclusion/exclusion criteria; they allow the doctor to practice a little bit more the way they would in the real world with a patient that wasn’t on trial.

Because the traditional clinical trials do a great job of answering the question of “how do these medications work in the very restrictive population that they’re done in?” But we need to what happens when they’re released to the wild, so to speak. It’s really important that community practices be supported in conducting clinical research for oncology.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up